Karo Bio

Contact
karobio.com
+4686086000

Karo Bio AB

Hälsovägen 7, Novum
141 57 Huddinge
Sweden
+4686086000
karobio.com
Contact
Profile News
Contact

About Karo Bio

The mission of Karo Bio is to develop novel pharmaceuticals for treatment of metabolic diseases. The company is in an exciting stage of its development and is transforming from a drug discovery company to a company with preclinical and clinical development capabilities. I welcome you to our web site and encourage you to learn more about our clinical and preclinical programs and our partnerships.

Read more about Karo Bio
Facts about Karo Bio
  • Focus : Manufacturer
  • Industry : Pharma

News about Karo Bio

Karo Bio

03-Jan-2012 | business & finance

Karo Bio Enters Collaboration with Pfizer to Discover and Develop Innovative Drugs for Autoimmune Diseases

Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the ...

Read news
Karo Bio

19-Aug-2011 | people

Changes in Management Of Karo Bio AB

Karo Bio AB announced that Jens Kristensen, Chief Medical Officer and Vice President Preclinical Development and Regulatory affairs, leaves his position. Ac ...

Read news
Karo Bio

26-May-2011 | people

Karo Bio: Karo Bio’s CEO, Fredrik Lindgren, Leaves

Karo Bio AB communicated that Fredrik Lindgren will leave his position as CEO of the company. A new CEO will be appointed by the board at the board meeting ...

Read news
Karo Bio

05-Aug-2008 | research and development

Karo Bio Announces Successful Phase II Study with Eprotirome in Combination with Statin

Karo Bio has successfully completed a 12 week phase IIb study of eprotirome (KB2115) given to patients with dyslipidemia (elevated blood lipids). These ...

Read news
Karo Bio

14-Sep-2006 | business & finance

Karo Bio announces Merck has entered clinical development with estrogen receptor compound

Karo Bio announced that an estrogen receptor compound discovered as part of its research collaboration with Merck & Co., Inc. has entered Phase I clinical ...

Read news
Karo Bio

09-Aug-2006 | business & finance

Karo Bio and Wyeth extend research collaboration

Karo Bio announced that Wyeth and Karo Bio extended their atherosclerosis collaboration for an additional year until August 31, 2007. The primary objective ...

Read news
Karo Bio

17-Aug-2005 | business & finance

Karo Bio and Wyeth Extend Research Collaboration

Wyeth and Karo Bio have agreed to extend the research term of their atherosclerosis collaboration for an additional year until August 31, 2006 with the ...

Read news
Karo Bio

26-Jan-2005 | science

Clinical Trials Initiated and Significant Milestone Reached in the Collaboration Between Karo Bio and Merck & Co., Inc.

Clinical trials have been initiated for the most advanced compound in the drug discovery and development collaboration between Merck & Co., Inc. and Karo Bi ...

Read news
Show more news about Karo Bio

Here you will find Karo Bio AB